HOOPER, LUNDY & BOOKMAN, P.C. for ROCHE DIAGNOSTICS CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 3271 - Protecting Access to Diabetic Testing Supplies Act of 2017; S. 1914 - Protecting Access to Diabetes Supplies Act of 2017; Yet to be introduced House and Senate proposal for a regulatory framework for in-vitro clinical testing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARTIN A CORRY New | — |
| LISA LAYMAN New | SPA, Stabenow; SPA, Sen. Graham; LA, Sen. Bryan, LA, Sen. Chafee; CBO, PA |
Medicare/Medicaid MMM
H.R. 3271 - Protecting Access to Diabetic Testing Supplies Act of 2017; S. 1914 - Protecting Access to Diabetes Supplies Act of 2017; Yet to be introduced House and Senate proposal for a regulatory framework for in-vitro clinical testing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARTIN A CORRY New | — |
| LISA LAYMAN New | SPA, Stabenow; SPA, Sen. Graham; LA, Sen. Bryan, LA, Sen. Chafee; CBO, PA |
Chemicals/Chemical Industry CHM
H.R. 3271 - Protecting Access to Diabetic Testing Supplies Act of 2017; S. 1914 - Protecting Access to Diabetes Supplies Act of 2017; Yet to be introduced House and Senate proposal for a regulatory framework for in-vitro clinical testing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARTIN A CORRY New | — |
| LISA LAYMAN New | SPA, Stabenow; SPA, Sen. Graham; LA, Sen. Bryan, LA, Sen. Chafee; CBO, PA |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.